State
73,827 recalls have nationwide distribution and so reach Rhode Island. 3,054 additional recalls listed Rhode Island specifically in their distribution scope.
Of the 3,054 recalls naming Rhode Island we have scored against our rubric, 221 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 708 (23%) are Severe.
Which agencies issued them
These figures cover only the 3,054 recalls whose distribution notice names Rhode Island specifically. The 73,827 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Ameditech Inc is recalling 31,472 Benzodiazepine Strip Dip Card kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ImmuTest Cup 7-panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 10 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 1,680 ProScreen CLIA Wvd 12 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 5 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling Micro Screen 6 Panel Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Perrigo is recalling Equaline All Day Allergy tablets because they contain an impurity called cetirizine monosaccharide ester.
Ameditech is recalling 1,907 DrugCheck Waived 12 Panel Cup kits nationwide due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling DrugSmart 12 Test Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling Immutest 12 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 300 kits of the Thermo Fisher 6 Drug Cassette because the tests may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling iCup DX 6 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 1,909 Immutest 5 Pnl Drug Cup kits due to reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling iCup DX 10 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen Cup CLIA drug tests because they may show reduced reactivity for specific benzodiazepine compounds.
Ameditech is recalling 3,603 kits of 6 Panel Cup Body and Lid w/Adult (AU) because they show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 6 Panel Cassette kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 6 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 8 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling iCup DX 8 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling iCup DX 12 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Oasis Medical, Inc. is recalling HPMC Visoelastic syringes because the pH of the affected lots may not meet specifications at expiry.
Ameditech is recalling ProScreen 9 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Philips is recalling 30 Brilliance 64 CT systems because the perfusion scan feature may be unavailable on specific software versions.
Ameditech is recalling DrugSmart Dip tests because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.